Drp1 peptide inhibitor P110 (TFA)
Drp1 peptide inhibitor P110 (Compound P110) TFA is a selective Drp1 peptide inhibitor with neuroprotective properties. Drp1 peptide inhibitor P110 TFA can inhibit the activation of Drp1, prevent MPTP (HY-15608) -induced Drp1 mitochondrial translocation, and alleviate MPTP-induced dopaminergic neuron loss, dopaminergic nerve terminal damage, and behavioral deficits, and can be used in the study of Alzheimer's disease. Additionally, Drp1 peptide inhibitor P110 TFA can reduce mitochondrial damage and organ injury in animal models of Huntington's disease, cerebral ischemic injury, and myocardial infarction[1].
Product Specifications
UNSPSC
12352209
Target
Dynamin
Related Pathways
Cytoskeleton
Applications
Neuroscience-Neurodegeneration
Field of Research
Cardiovascular Disease; Neurological Disease
Purity
99.11
Smiles
Molecular Formula
C100H179N45O25·xC2HF3O2
Molecular Weight
2411.78 (free base)
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items